Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sight Sciences (SGHT) EBT (2020 - 2025)

Sight Sciences has reported EBT over the past 6 years, most recently at -$4.2 million for Q4 2025.

  • Quarterly results put EBT at -$4.2 million for Q4 2025, up 64.82% from a year ago — trailing twelve months through Dec 2025 was -$38.4 million (up 25.07% YoY), and the annual figure for FY2025 was -$38.4 million, up 25.07%.
  • EBT for Q4 2025 was -$4.2 million at Sight Sciences, up from -$8.2 million in the prior quarter.
  • Over the last five years, EBT for SGHT hit a ceiling of -$4.2 million in Q4 2025 and a floor of -$23.8 million in Q2 2022.
  • Median EBT over the past 5 years was -$14.4 million (2023), compared with a mean of -$14.7 million.
  • Biggest five-year swings in EBT: plummeted 112.05% in 2021 and later skyrocketed 64.82% in 2025.
  • Sight Sciences' EBT stood at -$15.8 million in 2021, then decreased by 6.69% to -$16.9 million in 2022, then soared by 36.79% to -$10.7 million in 2023, then fell by 10.55% to -$11.8 million in 2024, then soared by 64.82% to -$4.2 million in 2025.
  • The last three reported values for EBT were -$4.2 million (Q4 2025), -$8.2 million (Q3 2025), and -$11.9 million (Q2 2025) per Business Quant data.